Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramChief Commercial OfficerCIK 0001855298
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Merendino LaurenChief Commercial Officer |  DAWNDay One Biopharmaceuticals, Inc.Disposition to issuer | D | — 110.0K sh | Apr 23, 2026 traded Apr 23, 2026 | |
Merendino LaurenChief Commercial Officer |
| DAWNDay One Biopharmaceuticals, Inc. Disposition to issuer |
| D |
| — 60.2K sh |
| Apr 23, 2026 traded Apr 23, 2026 |
| 9 | Merendino LaurenChief Commercial Officer | DAWNDay One Biopharmaceuticals, Inc. Disposition to issuer | D | — 90.0K sh | Apr 23, 2026 traded Apr 23, 2026 |
| 9 | Merendino LaurenChief Commercial Officer | DAWNDay One Biopharmaceuticals, Inc. Disposition to issuer | D | — 90.0K sh | Apr 23, 2026 traded Apr 23, 2026 |
| 9 | Merendino LaurenChief Commercial Officer | DAWNDay One Biopharmaceuticals, Inc. Disposition to issuer | D | — 19.0K sh | Apr 23, 2026 traded Apr 23, 2026 |
| 9 | Merendino LaurenChief Commercial Officer | DAWNDay One Biopharmaceuticals, Inc. Disposition to issuer | D | — 25.8K sh | Apr 23, 2026 traded Apr 23, 2026 |
| 9 | Merendino LaurenChief Commercial Officer | DAWNDay One Biopharmaceuticals, Inc. Disposition to issuer | D | — 40.6K sh | Apr 23, 2026 traded Apr 23, 2026 |
| 9 | Merendino LaurenChief Commercial Officer | DAWNDay One Biopharmaceuticals, Inc. Disposition to issuer | D | — 69.4K sh | Apr 23, 2026 traded Apr 23, 2026 |
| 9 | Merendino LaurenChief Commercial Officer | DAWNDay One Biopharmaceuticals, Inc. Disposition to issuer | D | — 330.2K sh | Apr 23, 2026 traded Apr 23, 2026 |
| 9 | Merendino LaurenChief Commercial Officer | DAWNDay One Biopharmaceuticals, Inc. Grant or award | A | — 74.0K sh | Jan 30, 2026 traded Jan 30, 2026 |
| 9 | Merendino LaurenChief Commercial Officer | DAWNDay One Biopharmaceuticals, Inc. Grant or award | A | — 110.0K sh | Jan 30, 2026 traded Jan 30, 2026 |
| 9 | Merendino LaurenChief Commercial Officer | DAWNDay One Biopharmaceuticals, Inc. Grant or award | A | — 90.0K sh | Nov 7, 2025 traded Nov 6, 2025 |
| 9 | Merendino LaurenChief Commercial Officer | DAWNDay One Biopharmaceuticals, Inc. Disposition to issuer | D | — 90.0K sh | Nov 7, 2025 traded Nov 6, 2025 |
| 9 | Merendino LaurenChief Commercial Officer | DAWNDay One Biopharmaceuticals, Inc. Disposition to issuer | D | — 90.0K sh | Nov 7, 2025 traded Nov 6, 2025 |
| 9 | Merendino LaurenChief Commercial Officer | DAWNDay One Biopharmaceuticals, Inc. Grant or award | A | — 330.2K sh | Nov 7, 2025 traded Nov 6, 2025 |
| 9 | Merendino LaurenChief Commercial Officer | DAWNDay One Biopharmaceuticals, Inc. Grant or award | A | — 90.0K sh | Nov 7, 2025 traded Nov 6, 2025 |
| 9 | Merendino LaurenChief Commercial Officer | DAWNDay One Biopharmaceuticals, Inc. Disposition to issuer | D | — 330.2K sh | Nov 7, 2025 traded Nov 6, 2025 |